The rehabilitation window and where cell therapy might fit
Quick answer
After a stroke the brain's capacity to rewire peaks in the first 3-6 months, and structured rehabilitation remains the best-evidenced treatment. Cell therapy sits at the research stage, with the hope of reducing inflammation and encouraging new blood vessel growth around the damaged area.
Stroke damage splits into tissue that is already dead and a surrounding zone that can still be salvaged (the penumbra). Cell research targets that border zone, not the infarct core — which is exactly why timing of administration matters so much.
Practically, patients and families should weight the proven items first: blood pressure, diabetes and lipid control, prescribed antiplatelet therapy and a sustained rehabilitation programme. These determine long-term outcome more than anything else.
If you weigh cell therapy as an add-on, ask which cell type, which route, whether outcomes are scored on standard scales such as mRS or NIHSS, and what follow-up exists. Any offer promising you will definitely walk again should be treated as a red flag.
The later it is, the smaller the expected benefit as brain repair plateaus — though rehabilitation continues to help.
No. Recurrence prevention comes from blood pressure, diabetes and lipid control plus prescribed medication.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categoriesRelated topics: Brain & nerves